Lepu Biopharma (2157) Proposes New RSU Scheme and Sets Date for Second 2025 EGM

Bulletin Express11-28

Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing. Shareholders will review and vote on multiple special resolutions, chiefly focusing on the adoption of the Restricted Share Unit (RSU) Scheme (H Share) and a Scheme Mandate Limit.

According to the announcement, the proposed RSU Scheme aims to attract and retain employees deemed key to the company’s long-term growth, allowing eligible participants to receive RSUs under a total issue cap of up to 5% of the company’s outstanding shares (excluding any treasury shares) as of the adoption date. The meeting will also consider related authorizations for directors to grant share awards and amend the Articles of Association if new shares are issued pursuant to the RSU Scheme.

The register of members for Lepu Biopharma’s H shares will be closed for transfer from December 15 to December 18, 2025, inclusive. Shareholders intending to appoint a proxy should submit the required forms at least 24 hours before the meeting. The full details and proxy forms are available on the Hong Kong Stock Exchange and the company’s website.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138630594?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-28 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138630594","market":"hk","top_or_hot":-1,"title":"Lepu Biopharma (2157) Proposes New RSU Scheme and Sets Date for Second 2025 EGM","media":"Bulletin Express","content":"<p>Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing. Shareholders will review and vote on multiple special resolutions, chiefly focusing on the adoption of the Restricted Share Unit (RSU) Scheme (H Share) and a Scheme Mandate Limit.</p>\n<p>According to the announcement, the proposed RSU Scheme aims to attract and retain employees deemed key to the company’s long-term growth, allowing eligible participants to receive RSUs under a total issue cap of up to 5% of the company’s outstanding shares (excluding any treasury shares) as of the adoption date. The meeting will also consider related authorizations for directors to grant share awards and amend the Articles of Association if new shares are issued pursuant to the RSU Scheme.</p>\n<p>The register of members for Lepu Biopharma’s H shares will be closed for transfer from December 15 to December 18, 2025, inclusive. Shareholders intending to appoint a proxy should submit the required forms at least 24 hours before the meeting. The full details and proxy forms are available on the Hong Kong Stock Exchange and the company’s website.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lepu Biopharma (2157) Proposes New RSU Scheme and Sets Date for Second 2025 EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLepu Biopharma (2157) Proposes New RSU Scheme and Sets Date for Second 2025 EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-28 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing. Shareholders will review and vote on multiple special resolutions, chiefly focusing on the adoption of the Restricted Share Unit (RSU) Scheme (H Share) and a Scheme Mandate Limit.</p>\n<p>According to the announcement, the proposed RSU Scheme aims to attract and retain employees deemed key to the company’s long-term growth, allowing eligible participants to receive RSUs under a total issue cap of up to 5% of the company’s outstanding shares (excluding any treasury shares) as of the adoption date. The meeting will also consider related authorizations for directors to grant share awards and amend the Articles of Association if new shares are issued pursuant to the RSU Scheme.</p>\n<p>The register of members for Lepu Biopharma’s H shares will be closed for transfer from December 15 to December 18, 2025, inclusive. Shareholders intending to appoint a proxy should submit the required forms at least 24 hours before the meeting. The full details and proxy forms are available on the Hong Kong Stock Exchange and the company’s website.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物-B","start_time":0,"source_url":"","article_id":"1138630594","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138630594","pubTimestamp":1764331369,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物-B"},"translate_title":"乐普生物(2157)提出新的受限制股份单位计划并确定2025年第二次临时股东大会日期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing. Shareholders will review and vote on multiple special resolutions, chiefly focusing on the adoption of the Restricted Share Unit (RSU) Scheme (H Share) and a Scheme Mandate Limit.\nAccording to the announcement, the proposed RSU Scheme aims to attract and retain employees deemed key to the company’s long-term growth, allowing eligible participants to receive RSUs under a total issue cap of up to 5% of the company’s outstanding shares (excluding any treasury shares) as of the adoption date. The meeting will also consider related authorizations for directors to grant share awards and amend the Articles of Association if new shares are issued pursuant to the RSU Scheme.\nThe register of members for Lepu Biopharma’s H shares will be closed for transfer from December 15 to December 18, 2025, inclusive. Shareholders intending to appoint a proxy should submit the required forms at least 24 hours before the meeting. The full details and proxy forms are available on the Hong Kong Stock Exchange and the company’s website.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138630594","isCrawlerRequest":true}